最新的 NIH 通知和公告，请注意此列表将每周更新，因此请查看更多 NIH 资助机会。
单击 这里 to find previous NIH funding lists
|
机会 ＃ |
选项 |
截止时间 |
|
Notice of NICHD Participation in PAR-21-275, "The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional)" |
|
|
|
Register Today for the 2021 NIH Virtual Seminar on Program Funding and Grants Administration - Nov. 1-4 |
|
|
|
Notice of Special Interest (NOSI): Biologic Factors Underlying Dental, Oral, and Craniofacial Health Disparities |
|
|
|
Notice of Information: Upcoming Prize Competition Announcement for the NIH Technology Accelerator Challenge - Maternal Health |
|
|
|
Modern Equipment for Shared-use Biomedical Research Facilities: Advancing Research-Related Operations (R24 Clinical Trials Not Allowed) |
1月2021日，XNUMX年 Webinar October 22, 2-4 pm EDT |
|
|
Genomic Curriculum Development for Medical Students (R25 Clinical Trial Not Allowed) |
25月2022, XNUMX |
|
|
Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trials Not Allowed) |
21年2024月XNUMX日 |
|
|
HEAL Initiative: Advancing Health Equity in Pain Management (R61/R33 Clinical Trial Required) |
9月2021日，XNUMX年 |
|
|
Pilot Practice-based Research for Primary Care Suicide Prevention (R34 Clinical Trial Optional) |
21年2022月XNUMX日 |
|
|
Neurosurgeon Research Career Development Program (NRCDP) (K12 Independent Clinical Trial Not Allowed) |
15月2021日，XNUMX年 |
|
|
Pediatric Obesity Discovery Science Research to Improve Understanding of Risk and Causal Mechanisms for Obesity in Early Life (R01 Clinical Trial Optional) |
8月2022日, XNUMX年 |
|
|
Role of Astrocytes in Degeneration of the Neurovascular Unit in AD/ADRDs (R01 Clinical Trial Not Allowed) |
4月2022日, XNUMX年 |
|
|
HEAL initiative: Pharmacotherapies to Reverse Opioid Overdose Induced Respiratory Depression Without Central Opioid Withdrawal (Target Validation and Candidate Therapeutic Development) (UG3/UH3 Clinical Trials Not Allowed) |
3月2021日，XNUMX年 |
|
|
Systems Biology for Infectious Diseases (U19 Clinical Trial Not Allowed) |
14月2022, XNUMX |
|
|
NINDS Institutional AD/ADRD Research Training Program (T32 Clinical Trial Not Allowed) |
五月25日, 2024 |
|
|
INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Exploratory/Developmental Research Grant Award (R21 Clinical Trial Not Allowed) |
3年2022月XNUMX日 |
|
|
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) |
5年2024月XNUMX日 |
|
|
National Cancer Institute Youth Enjoy Science Research Education Program (R25 Clinical Trial Not Allowed) |
28年2023月XNUMX日 |
|
|
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT U01 Clinical Trial Not Allowed) |
19年2021月XNUMX日 |
|
|
NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required) |
12年2021月XNUMX日 |
|
|
High-Resolution Exploration of the Human Islet Tissue Environment [HIRN Human Pancreas Analysis Consortium (HPAC)] (U01 - Clinical Trial Not Allowed) |
3月2022日, XNUMX年 |
|
|
Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed) |
7年2024月XNUMX日 |
|
|
RFA-DK-21-503 [Related Opportunities] |
Limited Competition for the Continuation of Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed) |
30年2021月XNUMX日 |
|
American Women: Assessing Risk Epidemiologically (AWARE) (R01 Clinical Trial Optional) 卫生和人类服务部 |
9月2021日，XNUMX年 |
|
|
Fentanyl and its Analogs: Effects and Consequences for Treatment of Addiction and Overdose (UG3/UH3 Clinical Trial Optional) |
11年2021月XNUMX日 |
|
|
Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed) |
10年2024月XNUMX日 |
|
|
Clinical and Biological Measures of TBI-related Dementia Including Chronic Traumatic Encephalopathy (R01 Clinical Trial Not Allowed) |
10年2021月XNUMX日 |
|
|
Multi-Disciplinary Collaborations to Understand Mechanisms of Systemic Immune Signaling and Inflammation in ADRD and its Progression (R01 Clinical Trial Not Allowed) |
22年2021月XNUMX日 |
|
|
Biomarkers for the Lewy Body Dementias (U01 Clinical Trial Not Allowed) |
22年2021月XNUMX日 |
|
|
New Investigators to Promote Workforce Diversity in Genomics, Bioinformatics, or Bioengineering and Biomedical Imaging Research (R01 Clinical Trial Optional) |
22月2024日, XNUMX年 |
|
|
Cardiovascular Biorepository for Type 1 Diabetes (U24 Clinical Trial Not Allowed) |
20年2021月XNUMX日 |
|
|
Implementing and Sustaining Evidence-Based Mental Health Practices in Low-Resource Settings to Achieve Equity in Outcomes (R34 Clinical Trial Required ) |
7年2024月XNUMX日 |
|
|
Primary Care-Based Screening and Intervention Development for Prevention of Abuse in Older and Vulnerable Adults in the Context of Alzheimers Disease and Related Dementias (R61/R33 Clinical Trial Required) |
20年2021月XNUMX日 |
|
|
NIAID Research Education Program Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed) |
7年2023月XNUMX日 |
|
|
Effectiveness of School-Based Health Centers to Advance Health Equity (R01 Clinical Trial Optional) |
7月2025, XNUMX |
|
|
Cancer Target Discovery and Development (CTD2) (U01 Clinical Trial Not Allowed) |
6年2022月XNUMX日 |
|
|
Technology Development for Single-Molecule Protein Sequencing (R01 Clinical Trial not allowed) |
15年2023月XNUMX日 |
|
|
Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern (U19 Clinical Trial Not Allowed) |
22年2021月XNUMX日 |
|
|
Technology Development for Single-Molecule Protein Sequencing (R01 Clinical Trial not allowed) |
15年2023月XNUMX日 |
|
|
Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 Clinical Trials Not Allowed) |
五月7日, 2023 |
|
|
预防医疗保健相关感染的大型研究项目 (R01) |
五月26日, 2025 |
|
|
HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R01 Clinical Trial Not Allowed) |
19年2021月XNUMX日 |
|
|
Data Enhancements and Analyses to Clarify the Relationship between Education and Cognitive Function (including AD/ADRD) (R01 Clinical Trial Not Allowed) |
20年2021月XNUMX日 |
|
|
Elucidating the Effects of ART on Neuronal Function in the Context of SUD and HIV (R01 - Clinical Trials Not Allowed) |
2月2022日, XNUMX年 |
|
|
Mechanisms of Alcohol Tolerance (R21/R33 Clinical Trial Optional) |
7年2024月XNUMX日 |
|
|
Large Scale Mapping and/or Molecular Profiling of Ensembles and/or Cell-Types Mediating Opioid Action in the Rodent Brain (R01 - Clinical Trial Not Allowed) |
15年2021月XNUMX日 |
|
|
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required) |
11月2024日, XNUMX年 |
|
|
Limited Competition: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed) |
7年2024月XNUMX日 |
|
|
NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed) |
4月2024日, XNUMX年 |
|
|
NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed) |
4月2024日, XNUMX年 |
|
|
High Resolution Mapping of Biomolecules in Brain Cells in Aging and Alzheimers Disease (R01 Clinical Trial Not Allowed) |
28年2021月XNUMX日 |
|
|
HEAL Initiative: Planning Studies for Initial Analgesic Development [Small Molecules and Biologics] (R61 Clinical Trial Not Allowed) |
10年2023月XNUMX日 |
|
|
NIA Postdoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD (F32 Clinical Trial Not Allowed) |
八月 8, 2024 |
|
|
NIA Advanced Postdoctoral Career Transition Awards to Promote Diversity in Translational Research for AD/ADRD (K99/R00 Clinical Trial Not Allowed) |
五月7日, 2024 |
|
|
Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional) |
13年2023月XNUMX日 |
|
|
Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) |
五月7日, 2024 |
|
|
NINDS Efficacy Clinical Trials (UG3/UH3 Clinical Trial Required) |
五月7日, 2024 |
|
|
T32 Training Program for Institutions That Promote Diversity (T32 Clinical Trial Not Allowed) |
28月2024日, XNUMX年 |
|
|
Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 - Clinical Trial Optional) |
五月7日, 2024 |
|
|
Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Optional) |
五月7日, 2024 |
|
|
BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional) |
20月2024日, XNUMX年 |
|
|
Standardization of C-Peptide and HbA1C Measurements Program (U01 Clinical Trial Not Allowed) |
20年2021月XNUMX日 |
|
|
Screening and Functional Validation of Human Birth Defects Genomic Variants (R01 Clinical Trial Not Allowed) |
五月7日, 2025 |
|
|
Limited Competition: Development and Renovation of Research Space for HIV/AIDS Research at Institutions Serving Underrepresented Populations or Located in Institutional Development Award (IDeA)-eligible States (C06 Clinical Trial Not Allowed) |
6月2022, XNUMX |
|
|
Translational Neural Devices (UG3/UH3 - Clinical Trial Optional) |
20月2024日, XNUMX年 |
|
|
NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed)
|
五月7日, 2024 |
|
|
Limited Competition: Development and Renovation of Research Space for HIV/AIDS Research at Institutions Serving Underrepresented Populations or Located in Institutional Development Award (IDeA)-eligible States (C06 Clinical Trial Not Allowed) |
6月2022, XNUMX |
|
|
BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access and Manipulation to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed) |
12年2022月XNUMX日 |
|
|
Limited Competition: Clinical and Translational Science Awards (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Not Allowed) |
21年2023月XNUMX日 |
|
|
Research on Autism Spectrum Disorders (R21 Clinical Trial Optional) |
16月2024日, XNUMX年 |
|
|
Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional) |
10月2024, XNUMX |
|
|
Enhancement or Sustainment of Data Science Tools for Infectious and Immune-Mediated diseases (U24 Clinical Trial Not Allowed) |
6年2023月XNUMX日 |
|
|
Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed) |
五月7日, 2024 |
|
|
The Autoantigens and Neoantigens Function in the Etiology and Pathophysiology of Type 1 Diabetes (R01 Clinical Trial Optional) |
9月2022日, XNUMX年 |
|
|
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required) |
15月2024日, XNUMX年 |
|
|
Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required) |
15月2024日, XNUMX年 |
|
|
NINDS Institutional Research Training Program (T32 - Clinical Trial Not Allowed) |
五月25日, 2023 |
|
|
NEI Translational Research Program (TRP) on Therapy for Visual Disorders (R24 Clinical Trial Optional) |
四月13日, 2023 |
|
|
Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional) |
7月2024, XNUMX |
|
|
Limited Competition for the Continuation or Revision of Multisite Clinical Trial Clinical Coordinating Center (Collaborative UH3 Clinical Trial Optional) |
27年2023月XNUMX日 |
|
|
NIA MSTEM: Advancing Diversity in Aging Research through Undergraduate Education (R25 - Independent Clinical Trial Not Allowed) |
五月25日, 2023 |
|
|
NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed) |
五月7日, 2024 |
|
|
nstitutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (T32) |
25年2023月XNUMX日 |
|
|
NIDCD Research Career Enhancement Award for Established Investigators (K18 Independent Basic Experimental Studies with Humans Required) |
7月2024, XNUMX |
|
|
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R61/R33 Clinical Trial Required) |
7月2024, XNUMX |
|
|
Priority HIV/AIDS Research within the Mission of the NIDDK (R01 Clinical Trial Optional) |
7月2024, XNUMX |
|
|
NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional) |
15月2024日, XNUMX年 |
|
|
NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3 Clinical Trial Optional) |
25年2023月XNUMX日 |
|
|
NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional) |
26年2023月XNUMX日 |
|
|
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional) |
17年2023月XNUMX日 |
|
|
NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required) |
7月2024, XNUMX |
|
|
Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional) |
7年2023月XNUMX日 |
|
|
Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R01 Clinical Trial Optional) |
15年2022月XNUMX日 |
|
|
Exploring the Scientific Value of Existing or New Sepsis Human Biospecimen Collections (R21/R33 - Clinical Trial Not Allowed) |
16年2022月XNUMX日 |
|
|
|
Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R34 Clinical Trial Optional) |
15年2022月XNUMX日 |
|
Mechanistic Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) |
2月2022日，XNUMX年 |
|
|
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31) |
7年2023月XNUMX日 |
|
|
BRAIN Initiative Cell Census Network (BICCN) Scalable Technologies and Tools for Brain Cell Census (R01 Clinical Trial Not Allowed) |
10月2022日, XNUMX年 |
|
|
New Technologies for the In vivo Delivery of Gene Therapeutics for an HIV Cure (R01 Clinical Trial Not Allowed) |
7月2023日, XNUMX年 |
|
|
NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed) |
24月2023日, XNUMX年 |
|
|
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed) |
10年2023月XNUMX日 |
|
|
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) |
13年2023月XNUMX日 |
|
|
Successor-in-Interest (Type 6 Parent Clinical Trial Optional) |
23年2023月XNUMX日 |
|
|
Multidisciplinary Approaches to HIV-Associated Comorbidities and Prioritizing Intervention Targets (R01 Clinical Trial Not Allowed) |
7月2023, XNUMX |
|
|
Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional) |
27月2023日, XNUMX年 |
|
|
Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional) |
14月2021日，XNUMX年 |
|
|
Otolaryngology Residency Mentored Research Pathway (R25 Clinical Trial Not Allowed) |
13年2023月XNUMX日 |
|
|
Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations (R01 Clinical Trial Required) [Related Opportunities] |
18月2022, XNUMX |
|
|
Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers (P50 Clinical Trial Optional) |
五月17日, 2023 |
|
|
Development of the Fetal Immune System (R01 Clinical Trial Not Allowed) |
7月2023日，XNUMX年 |
|
|
Tobacco Control Policies to Promote Health Equity (R01 Clinical Trial Optional) |
7年2023月XNUMX日 |
|
|
Toward ElucidAting MechanismS of HIV Pathogenesis within the Mission of the NIDDK (Pathogenesis TEAMS) (R01 Clinical Trial Optional) |
17年2021月XNUMX日 |
|
|
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) |
20年2022月XNUMX日 |
|
|
NLM Information Resource Grants to Reduce Health Disparities (G08 Clinical Trial Not Allowed) |
21年2022月XNUMX日 |
|
|
Research to Improve Native American Health (R21 Clinical Trials Optional) |
7年2023月XNUMX日 |
|
|
Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed) |
7年2023月XNUMX日 |
|
|
BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional) |
14年2023月XNUMX日 |
|
|
Core Infrastructure Support for Cancer Epidemiology Cohorts (U01 Clinical Trial Not Allowed) |
9年2022月XNUMX日 |
|
|
Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed) |
四月15日, 2022 |
|
|
NIEHS Research Intensive Short Courses and Educational Opportunities (NIEHS RISE) (R25 Clinical Trial Not Allowed) |
28年2023月XNUMX日 |
|
|
NIDA 核心“卓越中心”资助计划（P30 临床试验可选） |
17年2022月XNUMX日 |
|
|
Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects (R21 Clinical Trial Not Allowed) |
五月30日, 2023 |
|
|
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33) |
五月7日, 2023 |
|
|
NIDA 药物使用和药物使用障碍研究指导临床科学家发展计划奖（K12 临床试验可选） |
15年2023月XNUMX日 |
|
|
HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed) |
7年2022月XNUMX日 |
|
|
针对与快感缺失相关的大脑系统的行为任务（需要对人类进行 R01 基础实验研究） |
7年2023月XNUMX日 |
|
|
Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01) |
8年2023月XNUMX日 |
|
|
Advancing Genomic Medicine Research (Clinical Trial Optional) (R21) |
13月2023日, XNUMX年 |
|
|
Advancing Genomic Medicine Research (Clinical Trial Optional) (R01) |
13月2023日, XNUMX年 |
|
|
Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes (K18 Basic Experimental Studies with Humans Required) |
17月2023日, XNUMX年 |
|
|
NCCIH Natural Product Mid Phase Clinical Trial Cooperative Agreement (U01 Clinical Trial Required) |
五月7日, 2023 |
|
|
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) |
五月7日, 2023 |
|
|
HIV Infection of the Central Nervous System (R01 Clinical Trial Not Allowed) |
五月7日, 2023 |
|
|
Substance Use/Substance Use Disorder Dissertation Research Award (R36 - Clinical Trials Optional) |
五月7日, 2023 |
|
|
Independent Scientist Award (Parent K02 Independent Basic Experimental Studies with Humans Required) |
五月7日, 2023 |
|
|
Independent Scientist Award (Parent K02 - Independent Clinical Trial Required) |
五月7日, 2023 |
|
|
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) |
五月21日, 2023 |
|
|
National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional) |
五月7日, 2023 |
|
|
Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R21 Clinical Trials Not Allowed) |
五月7日, 2023 |
|
|
Mechanisms and Consequences of Sleep Disparities in the U.S. (R01 - Clinical Trial Not Allowed) |
14年2022月XNUMX日 |
|
|
Catalyzing Innovation in Pediatric Pharmacology Clinical Trial Design and Resource Access (X01 Clinical Trial Not Allowed) |
27月2023日, XNUMX年 |
|
|
Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed) |
28年2022月XNUMX日 |
|
|
PAR-20-150 |
NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional) |
16年2023月XNUMX日 |
|
Extracellular RNA carrier subclasses in processes relevant to Substance Use Disorders or HIV infection (R01- Clinical Trial Not Allowed) |
五月7日, 2023 |
|
|
Extracellular RNA carrier subclasses in processes relevant to Substance Use Disorders or HIV infection (R21- Clinical Trial Not Allowed) |
五月7日, 2023 |
|
|
NIDA Small Research Grant Program (R03 Clinical Trial Required) |
五月7日, 2023 |
|
|
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) |
LOI due: 30 days prior to app due date App due: February 9, 2022, August 9, 2022, February 9, 2023 |
|
|
Integrated Preclinical / Clinical AIDS Vaccine Development Program (IPCAVD) |
LOI due: 30 days prior to app due date App due: March 9, 2022 |
|
|
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) |
LOI due: 30 days prior to app due date App due: February 9, 2022, August 9, 2022, February 9, 2023 |
|
|
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental or Substance Use Disorders or Alcohol Disorder (U01 Clinical Trial Optional) |
LOI due: October 26, 2021; February 25, 2022 App due: November 26, 2021; March 25, 2022 |
|
|
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders, Substance Use Disorders, or Alcohol Use Disorder (U19 Clinical Trial Optional) |
LOI due: October 26, 2021; February 25, 2022 App due: November 26, 2021; March 25, 2022 |
|
|
Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase 3 - Transitional Centers (P30 Clinical Trial Optional |
五月27日, 2022 |
|
|
|
Animal and Biological Material Resource Centers (P40) (Clinical Trials Not-Allowed) |
26月2022, XNUMX 五月26日, 2022 27年2022月XNUMX日 |
|
|
Enhancing Regulatory Science for Advancing Pharmaceutical Quality and Manufacturing (U01) Clinical Trials Optional |
LOI due 30 days prior to app due date: 四月3日, 2022 |
|
Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed) |
28年2021月XNUMX日 26月2022日, XNUMX年 28年2022月XNUMX日 |
|
|
Small Research Grants for Analyses of Down Syndrome-related Research Data for the INCLUDE Project (R03 Clinical Trial Not Allowed) |
LOI due 30 days prior to app due date: 3年2021月XNUMX日 |
|
|
|
Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed) |
LOI due 30 days prior to app due date: 3年2021月XNUMX日 |
|
|
INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed) |
LOI due 30 days prior to app due date: 3年2021月XNUMX日 |
|
Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required) |
LOI due 30 days prior to app due date: 3年2021月XNUMX日 |
|
|
National Dental Practice-Based Research Network Infrastructure Access (X01 Clinical Trial Not Allowed) |
1年2022月XNUMX日 |
|
|
|
NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed) |
11月2022, XNUMX 10年2022月XNUMX日 |
|
Postbaccalaureate Research Education Program (R25 - Independent Clinical Trial Not Allowed) |
27月2022, XNUMX |
|
|
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Training for a Dental, Oral and Craniofacial Research Workforce (T32) |
LOI due dates: August 26, 2022 App due dates: September 26, 2022 |
|
|
Institutional Training for a Dental, Oral and Craniofacial Research Workforce (T90/R90 Independent Clinical Trial Not Allowed) |
LOI due dates: August 25, 2022 App due dates: September 26, 2022 |
|
|
BRAIN Initiative 高级博士后职业转型奖以促进多样性（需要 K99/R00 独立临床试验） |
February 10, 2022; June 8, 2022; October 11, 2022 |
|
|
Support of Competitive Research (SCORE) Research Advancement Award (SC1 Clinical Trial Not Allowed) |
January 25, 2022; May 25, 2022 |
|
|
Support of Competitive Research (SCORE) Pilot Project Award (SC2 Clinical Trial Not Allowed) |
January 25, 2022; May 25, 2022 |
|
|
Support of Competitive Research (SCORE) Research Continuance Award (SC3 Clinical Trial Not Allowed) |
January 25, 2022; May 25, 2022 |
|
|
NCMRR 早期职业研究奖（R03 临床试验可选） |
30月2022日, XNUMX年 |
|
|
NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32Clinical Trial Not Allowed) |
February 9, 2022, June 8,2022, and October 11, 2022 |
|
|
Human-Animal Interaction (HAI) Research (R01 Clinical Trial Optional) |
30年2021月XNUMX日 |
|
|
Human-Animal Interaction (HAI) Research (R03 Clinical Trial Optional) |
30年2021月XNUMX日 |
|
|
Human-Animal Interaction (HAI) Research (R21 Clinical Trial Optional) |
30年2021月XNUMX日 |
|
|
Integrative Research on Polysubstance Abuse and Disorder (R61/R33 Clinical Trial Optional) |
November 17, 2021, March 17, 2022, July 19, 2022, November 7, 2022 |
|
|
Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations (U01 Clinical Trial Not Allowed) |
15年2022月XNUMX日 |
|
|
HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required) |
January 6, 2022, April 6, 2022, and September 8, 2022 |
|
|
HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed) |
January 6, 2022, April 6, 2022, and September 8, 2022 |
|
|
HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required) |
January 6, 2022, April 6, 2022, and September 8, 2022 |
